CIK 0001841330 · <br>Emerging growth company
Pasithea Therapeutics Corp.
Sign in to watch- Ticker
- KTTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851591963
- Phone
- (702) 514-4174
- Business address
- 1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | Coastlands Capital LP 10% owner | Purchase | +100,000 | $0.53 | $53K | 3,835,035 |
| 2026-05-01 | Marques Tiago Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,756,069 | 1,756,069 | ||
| 2026-05-01 | STEINMAN LAWRENCE Director | Grant or award · Stock Option (right to buy) | +152,783 | 152,783 | ||
| 2026-05-01 | Dumesnil Simon Director | Grant or award · Stock Option (right to buy) | +152,783 | 152,783 | ||
| 2026-05-01 | Schneiderman Daniel H Chief Financial Officer | Grant or award · Stock Option (right to buy) | +1,129,323 | 1,129,323 | ||
| 2026-05-01 | Krishnan Kartik Chief Medical Officer | Grant or award · Stock Option (right to buy) | +1,129,323 | 1,129,323 | ||
| 2026-05-01 | Leahy Emer Director | Grant or award · Stock Option (right to buy) | +152,783 | 152,783 | ||
| 2026-05-01 | Novak Alfred J Director | Grant or award · Stock Option (right to buy) | +152,783 | 152,783 | ||
| 2025-11-28 | STEINMAN LAWRENCE Director | Purchase | +133,333 | $0.75 | $100K | 199,691 |
| 2025-11-28 | Schneiderman Daniel H Chief Financial Officer | Grant or award | +26,667 | $0.75 | $20K | 26,667 |
| 2025-11-28 | Marques Tiago Chief Executive Officer | Purchase | +33,333 | $0.75 | $25K | 73,334 |
| 2025-11-28 | Dumesnil Simon Director | Purchase | +33,333 | $0.75 | $25K | 35,833 |
| 2025-11-28 | Leahy Emer Director | Grant or award | +33,333 | $0.75 | $25K | 33,333 |
| 2025-10-24 | STEINMAN LAWRENCE Director | Grant or award · Stock Option (right to buy) | +242,913 | 242,913 | ||
| 2025-10-24 | Schneiderman Daniel H Chief Financial Officer | Grant or award · Stock Option (right to buy) | +317,266 | 317,266 | ||
| 2025-10-24 | Novak Alfred J Director | Grant or award · Stock Option (right to buy) | +42,913 | 42,913 | ||
| 2025-10-24 | Marques Tiago Chief Executive Officer | Grant or award · Stock Option (right to buy) | +493,341 | 493,341 | ||
| 2025-10-24 | Leahy Emer Director | Grant or award · Stock Option (right to buy) | +42,913 | 42,913 | ||
| 2025-10-24 | Dumesnil Simon Director | Grant or award · Stock Option (right to buy) | +42,913 | 42,913 | ||
| 2025-05-12 | Marques Tiago Chief Executive Officer | Sale | −960 | $0.83 | $792 | 40,001 |
Page 1 of 4 · 79 trades